| SPARK: A US cohort of 50,000 families to accelerate autism research P Feliciano, AM Daniels, LAG Snyder, A Beaumont, A Camba, A Esler, ... Neuron 97 (3), 488-493, 2018 | 373 | 2018 |
| Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen SJF Macdonald, KG Watson, R Cameron, DK Chalmers, DA Demaine, ... Antimicrobial agents and chemotherapy 48 (12), 4542-4549, 2004 | 123 | 2004 |
| The discovery of GSK221149A: a potent and selective oxytocin antagonist J Liddle, MJ Allen, AD Borthwick, DP Brooks, DE Davies, RM Edwards, ... Bioorganic & medicinal chemistry letters 18 (1), 90-94, 2008 | 100 | 2008 |
| Design and application of a DNA-encoded macrocyclic peptide library Z Zhu, A Shaginian, LSC Grady, T O’Keeffe, XE Shi, CP Davie, ... ACS Chemical Biology 13 (1), 53-59, 2018 | 99 | 2018 |
| Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase KG Watson, R Cameron, RJ Fenton, D Gower, S Hamilton, B Jin, ... Bioorganic & medicinal chemistry letters 14 (6), 1589-1592, 2004 | 84 | 2004 |
| Pyridyl-2, 5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency AD Borthwick, J Liddle, DE Davies, AM Exall, C Hamlett, DM Hickey, ... Journal of Medicinal Chemistry 55 (2), 783-796, 2012 | 67 | 2012 |
| Design and Synthesis of Pyrrolidine-5,5-trans-lactams (5-Oxohexahydropyrrolo[3,2-b]pyrroles) as Novel Mechanism-Based Inhibitors of Human Cytomegalovirus … AD Borthwick, AJ Crame, PF Ertl, AM Exall, TM Haley, GJ Hart, AM Mason, ... Journal of medicinal chemistry 45 (1), 1-18, 2002 | 59 | 2002 |
| MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo‐allergic and anaphylactoid reactions J Grimes, S Desai, NW Charter, J Lodge, R Moita Santos, A Isidro‐Llobet, ... Pharmacology research & perspectives 7 (6), e00547, 2019 | 52 | 2019 |
| Synthesis of 6-substituted-4-hydroxy-2-pyridinones via intramolecular ketene trapping of functionalized enamine-dioxinones BH Patel, AM Mason, AGM Barrett Organic letters 13 (19), 5156-5159, 2011 | 47 | 2011 |
| Structure-and property-based design of factor Xa inhibitors: pyrrolidin-2-ones with acyclic alanyl amides as P4 motifs RJ Young, M Campbell, AD Borthwick, D Brown, CL Burns-Kurtis, C Chan, ... Bioorganic & medicinal chemistry letters 16 (23), 5953-5957, 2006 | 44 | 2006 |
| Kernel methods for predicting yields of chemical reactions AL Haywood, J Redshaw, MWD Hanson-Heine, A Taylor, A Brown, ... Journal of Chemical Information and Modeling 62 (9), 2077-2092, 2021 | 39 | 2021 |
| Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitors NS Watson, D Brown, M Campbell, C Chan, L Chaudry, MA Convery, ... Bioorganic & medicinal chemistry letters 16 (14), 3784-3788, 2006 | 37 | 2006 |
| P.; Weingarten, GG; Woolven AD Borthwick, AJ Crame, PF Ertl, AM Exall, TM Haley, GJ Hart, AM Mason, ... J. Med. Chem 45, 1, 2002 | 34 | 2002 |
| Structure and property based design of factor Xa inhibitors: Biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs RJ Young, AD Borthwick, D Brown, CL Burns-Kurtis, M Campbell, C Chan, ... Bioorganic & medicinal chemistry letters 18 (1), 28-33, 2008 | 33 | 2008 |
| Compounds useful in the treatment of inflammatory diseases DR Armour, D Brown, MS Congreve, PM Gore, DVS Green, S Holman, ... US Patent 6,867,192, 2005 | 33 | 2005 |
| Conversion of α-Amino Acids into Bioactive o-Aminoalkyl Resorcylates and Related Dihydroxyisoindolinones BH Patel, AM Mason, H Patel, RC Coombes, S Ali, AGM Barrett The Journal of Organic Chemistry 76 (15), 6209-6217, 2011 | 32 | 2011 |
| Structure and property based design of factor Xa inhibitors: Pyrrolidin-2-ones with biaryl P4 motifs RJ Young, AD Borthwick, D Brown, CL Burns-Kurtis, M Campbell, C Chan, ... Bioorganic & medicinal chemistry letters 18 (1), 23-27, 2008 | 32 | 2008 |
| Beliefs in vaccine as causes of autism among SPARK cohort caregivers E Fombonne, RP Goin-Kochel, BJ O'Roak, L Abbeduto, G Aberbach, ... Vaccine 38 (7), 1794-1803, 2020 | 31 | 2020 |
| Multivalent neuraminidase inhibitor conjugates WY Wu, MD Dowle, B Jin, SJF Macdonald, AMM Mason, D McConnell, ... US Patent 7,205,333, 2007 | 30 | 2007 |
| Pyrrolidine-5, 5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability AD Borthwick, AM Exall, TM Haley, DL Jackson, AM Mason, ... Bioorganic & medicinal chemistry letters 12 (13), 1719-1722, 2002 | 29 | 2002 |
